On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Alternet Systems, Inc. (ALYI) is a Fintech with a Future

The financial tech, or “fintech,” phenomenon is changing the landscape of financial services. Traditional ways of providing financial services such as making payments, accepting deposits, and lending and risk management are being abandoned as new channels, made possible by digital technology, are opened up. Technological innovation hasn’t just given rise to a new type of […]

International Stem Cell Corp. (ISCO) Publishes Results from Preclinical Study of ISC-hpNSC® for Treatment of Parkinson’s Disease

Before the opening bell, International Stem Cell Corp. (OTCQB: ISCO) announced the publication of results from a 12-month preclinical, non-human primate study. The data highlights the safety and efficacy of ISCO’s proprietary human parthenogenetic stem cells-derived neural stem cells (ISC-hpNSC®) for the treatment of Parkinson’s disease. According to the results of this study, transplantation of […]

Rennova Health, Inc.’s (RNVA) Focus on Compliance and Provider Contracts Reflects Background of Executive Team

Rennova Health, Inc. (NASDAQ: RNVA), Florida-based provider of technologies and services to the healthcare industry, has successfully faced a number of industry-wide challenges in recent years due to the steadfast focus on strict compliance by its executive team and the resulting potential that approach offers toward expanding provider contracts. It’s an accomplishment based upon a […]

SeeThruEquity Conference Brings Together Microcap Companies and Investors in New York City

Yesterday, the 5th Annual SeeThruEquity Conference took place at Convene in New York City, connecting more than 30 presenting companies with microcap-focused investors, sponsors and industry professionals. The conference featured 30-minute presentations from each of the presenting companies, as well as opportunities for prospective investors to meet one-on-one with the companies’ management teams. In total, […]

Content Checked (CNCK) Nutritionist Pens Article for WhoSay

For months, Content Checked Holdings, Inc. (OTCQB: CNCK) has been securing coverage in high-profile media outlets in an effort to get the word out about its family of dietary apps. The increasingly-recognizable brand has already garnered attention from Forbes, USA Today, ABC, CBS, NBC, Fox, Los Angeles Business Journal, Yahoo, and a number of other […]

OurPet’s Company (OPCO) Announces Sponsorship of 65th Annual BetterInvesting National Convention

Before the opening bell, OurPet’s Company (OTCQX: OPCO) announced its sponsorship of the 65th Annual BetterInvesting National Convention in Chantilly, Virginia. As part of this sponsorship, Dr. Steven Tsengas, chief executive officer of OPCO, and Scott Mendes, the company’s chief financial officer, were given the opportunity to present OurPet’s Company’s corporate story to a group […]

In a World Increasingly Disconnected from the Grid, Oakridge Global Energy Solutions’ (OGES) Lithium-ion Batteries Reset the Connection

A recent white paper (http://dtn.fm/Psz16) from Cisco (NASDAQ: CSCO) illustrates dramatically how smartphones and other mobile devices have replaced dogs as man’s (and woman’s) best friend. It estimates that about 563 million mobile devices and connections were added, globally, in 2015. Worldwide, there are now close to 8 billion devices and connections on the planet, […]

 

From Our Blog

Longeveron Inc. (NASDAQ: LGVN) Discusses 2023 Progress and 2024 Plans in Corporate Update

March 28, 2024

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicine for life-threatening conditions with unmet medical needs, recently released its full-year results for the period ended December 31, 2023, and provided a corporate update (https://ibn.fm/iORBu). Results from multiple studies using Longeveron’s lead investigational therapeutic candidate, Lomecel-B(TM), were announced by the company last year. “In 2023 […]

Rotate your device 90° to view site.